American Oriental Bioengineering, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
American Oriental Bioengineering, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					                American Oriental Bioengineering, Inc. - Pharmaceuticals & Healthcare -
                                     Deals and Alliances Profile
       Reference Code: GDPH26111D                                                                                                             Publication Date: APR 2013

      Company Overview                                                                                        Key Facts
      American Oriental Bioengineering, Inc. (AOBO) is an integrated pharmaceutical
                                                                                                              American Oriental Bioengineering, Inc.,
      company. The company manufactures and commercializes pharmaceutical and
                                                                                                              Pharmaceuticals & Healthcare, Key Facts
      healthcare products. It provides pharmaceutical manufacturing, pharmaceutical
      distributors, research and development, raw material plantations, holistic healthcare                    Web Address                       www.bioaobo.com
      and nutraceutical products. AOBO also offers treatment and over-the-counter
                                                                                                               Revenue (US$ million)                            NA
      pharmaceutical products, and nutraceutical products. Its pharmaceutical products
      include shuanghuanlian lyophilized injection powder, an antiviral injection which is                     Number of Employees                              NA
      used for the treatment of flu symptoms, upper respiratory infections, mild                               GlobalData
      pneumonia, and tonsillitis; and jieyuan tablets for cough.

      Financial Deals Landscape
        American Oriental Bioengineering, Inc., Pharmaceuticals &                         American Oriental Bioengineering, Inc., Pharmaceuticals &
        Healthcare, Deals by Type, 2007 to YTD 2013                                       Healthcare, Deals By Year, 2007 to YTD 2013


                                                                                                                 3
                                                                                                          3


                                                                                           No. of Deals
                                                                                                                          2
                                                                                                          2


                                                                                                          1

                                                                                                                                    0     0      0        0         0
                                                                                                          0
                                                                                                               2007      2008    2009    2010   2011     2012   YTD
                                                                                                                                                                2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         American Oriental Bioengineering, Inc., Pharmaceuticals &                        American Oriental Bioengineering, Inc., Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013

                         6     5
          No. of Deals




                                                                                           No. of Deals




                         5                                                                                1
                         4                                                                                           1          1         1          1          1
                         3
                         2
                         1               0        0        0         0
                         0
                              Asia-    Europe   Middle   North    South                                   0
                             Pacific             East    Americ    and                                          Central        Male     Mouth Muscul Over-
                                                 and       a      Central                                       Nervou        Health     And    oskelet   the-
                                                Africa            Americ                                          s                     Dental    al    Counte
                                                                    a                                           System                  Disorde             r
                                                                                                                                           rs           H ealt …


         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          from 2006 onwards, GlobalData




American Oriental Bioengineering, Inc. - Pharmaceuticals &                                                                                      Reference Code: GDPH26111D
Healthcare - Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                 Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       American Oriental Bioengineering, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .................................... 4
       American Oriental Bioengineering, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ..................................... 5
       American Oriental Bioengineering, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013................................. 6
       American Oriental Bioengineering, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ...................... 7
       American Oriental Bioengineering, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 .................................. 8
       American Oriental Bioengineering, Inc., Pharmaceuticals & Healthcare, Deal Details ....................................................................... 9
          Partnerships.................................................................................................................................................................................... 9
             American Oriental Bioengineering Enters Into Co-Development Agreement With China Aoxing Pharma .................................. 9
          Equity Offering .............................................................................................................................................................................. 11
             American Oriental Bioengineering Completes Public Offering Of $79 Million ........................................................................... 11
          Debt Offering ................................................................................................................................................................................ 13
             American Oriental Bioengineering Completes Offering Of Convertible Senior Notes Due 2015 For $115 Million..................... 13
          Acquisition .................................................................................................................................................................................... 15
             American Oriental Bioengineering Acquires Guangxi Boke Pharma ......................................................................................... 15
             American Oriental Bioengineering Acquires Changchun Xinan Pharma ................................................................................... 16
       American Oriental Bioengineering, Inc. - Key Competitors............................................................................................................... 17
       Key Employees ................................................................................................................................................................................ 18
       Locations And Subsidiaries .............................................................................................................................................................. 19
          Head Office ................................................................................................................................................................................... 19
          Other Locations & Subsidiaries ..................................................................................................................................................... 19
       Recent Developments ...................................................................................................................................................................... 20
          Corporate Communications .......................................................................................................................................................... 20
             Apr 06, 2012: American Oriental Bioengineering Receives NYSE Notice Of Delisting ............................................................. 20
          Other Significant Developments .................................
				
DOCUMENT INFO
Description: American Oriental Bioengineering, Inc. (AOBO) is an integrated pharmaceutical company. The company manufactures and commercializes pharmaceutical and healthcare products. It provides pharmaceutical manufacturing, pharmaceutical distributors, research and development, raw material plantations, holistic healthcare and nutraceutical products. AOBO also offers treatment and over-the-counter pharmaceutical products, and nutraceutical products. Its pharmaceutical products include shuanghuanlian lyophilized injection powder, an antiviral injection which is used for the treatment of flu symptoms, upper respiratory infections, mild pneumonia, and tonsillitis; and jieyuan tablets for cough. The company’s nutraceutical products include soybean peptide based drinks, tablets, powder, and instant coffee for health and well-being. American Oriental is headquartered in Beijing, China.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.